Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Testosterone affects brain functions and contributes to sex differences, influencing conditions like autism.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that more research is needed to fully understand the causes of PCOS.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.